Patents Assigned to Knoll Pharmaceuticals Co.
  • Method for treating central nervous system ischemia
    Patent number: 5571840
    Abstract: Central nervous system ischemia in a patient who has suffered an acute insult is treated by administering an effective amount of a thyroid hormone selected from the group levothyroxine, liothyronine, L-3,3',5'-triiodothyronine or L-3,5-diiodothyronine, or their sodium salts. The treatment is particularly applicable to the treatment of cerebral ischemia following cardiac arrest.
    Type: Grant
    Filed: June 6, 1994
    Date of Patent: November 5, 1996
    Assignees: The Regents of the University of Michigan, Knoll Pharmaceuticals Co.
    Inventors: Gilbert H. Mayor, Louis G. D'Alecy